Dr. Zhou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 800-647-2098Fax+1 314-362-3192
Education & Training
Vanderbilt University Medical CenterResidency, Internal Medicine, 2016 - 2019
Perelman School of Medicine at the University of PennsylvaniaClass of 2016
Certifications & Licensure
MO State Medical License 2019 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors Start of enrollment: 2024 Jun 30
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 5 citationsAssessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome.Omar H Butt, Alice Y Zhou, Paolo F Caimi, Patrick H Luckett, Julie K Wisch
JAMA Oncology. 2022-11-01 - 36 citationsMemory-like Differentiation Enhances NK Cell Responses to MelanomaNancy D. Marin, Bradley A. Krasnick, Michelle Becker-Hapak, Leah Conant, Simon P. Goedegebuure
Clinical Cancer Research. 2021-06-29 - 1212 citationsClinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein
Lancet. 2020-06-20
Press Mentions
Neurodegenerative Biomarker May Predict CAR T-cell Therapy-Related NeurotoxicityJanuary 26th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
